Business Context and Reporting Period
Creative Medical Technology Holdings, Inc. filed this Form 8-K on February 16, 2021. The company is incorporated in Nevada and maintains its principal executive offices in Phoenix, Arizona. The filing reports a specific corporate event rather than a standard financial reporting period.
Key Financial Metrics
This filing does not contain financial statements, revenue figures, profit data, cash flow information, margins, debt levels, or liquidity metrics. The document is a current report focused on a non-financial corporate event.
Material Changes
The material change reported is the filing of a patent application on February 16, 2021. The application covers the use of the company's ImmCelz® regenerative cell therapy for preventing the rejection of transplanted organs.
Guidance, Outlook, and Risks
The filing includes no financial guidance, forward-looking outlook, management commentary on financial performance, or discussion of specific risks and contingencies beyond the announcement of the patent application. No unusual items were reported.
Investor Verification Checklist
- Verify the status and scope of the patent application for ImmCelz® regarding organ transplant rejection.
- Confirm the regulatory pathway and clinical trial status of the ImmCelz® therapy.
- Review subsequent filings for any financial impact or milestones related to this intellectual property.